Benin vs Cameroon: Access to anti-retroviral drugs, male
Benin
78.0%
in 2024
Cameroon
79.0%
in 2024
Benin rank
51st
Cameroon rank
49th
Access to anti-retroviral drugs, male over time
- Benin
- Cameroon
How they compare
Cameroon currently reports 79.0% against 78.0% in Benin, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Cameroon ahead.
Benin ranks 51st and Cameroon ranks 49th of 141 countries.
Across the 3 decades both report, Benin averaged higher in 1 and Cameroon in 2.
Head to head by decade
| Decade | Benin | Cameroon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.6% | 4.7% | 1.1% | Cameroon |
| 2010s | 37.6% | 26.0% | 11.6% | Benin |
| 2020s | 66.2% | 68.2% | 2.0% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Benin or Cameroon?
- Cameroon, at 79.0% against 78.0% in Benin as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Benin and Cameroon?
- 1.0%, with Cameroon ahead.
- How many years of comparable data are there for Benin and Cameroon?
- 25 years are reported by both, from 2000 to 2024.
- How do Benin and Cameroon rank globally for access to anti-retroviral drugs, male?
- Benin ranks 51st and Cameroon ranks 49th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.